NWM
ABBV icon

Nova Wealth Management’s AbbVie ABBV Stock Holding History

Nova Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7K Buy
54
+20
+59% +$4.3K 0.01% 369
2026
Q1 		$7.45K Sell
34
-30
-47% -$6.66K ﹤0.01% 393
2025
Q4 		$14.6K Hold
64
– – 0.01% 317
2025
Q3 		$14.8K Hold
64
– – 0.01% 319
2025
Q2 		$11.8K Buy
64
+53
+482% +$9.85K 0.01% 349
2025
Q1 		$2.31K Buy
11
+4
+57% +$778 ﹤0.01% 436
2024
Q4 		$1.24K Buy
+7
New +$1.29K ﹤0.01% 330

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Nova Wealth Management's ABBV Position: Q2 2026 in Review

Nova Wealth Management increased its AbbVie (ABBV) stake by 59% in Q2 2026, buying an estimated $4.3K and bringing the position to 54 shares worth $13.7K. The position accounts for 0.01% of the portfolio, ranked #369.

Nova Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.8K in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Nova Wealth Management held 54 shares of AbbVie worth $13.7K as of Q2 2026.
  • Nova Wealth Management bought 20 AbbVie shares in Q2 2026, an estimated $4.3K.
  • AbbVie made up 0.01% of Nova Wealth Management's portfolio in Q2 2026, its #369 holding.
  • Nova Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Nova Wealth Management's AbbVie position peaked at $14.8K in Q3 2025.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Nova Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.